AGITGAustralasian Gastro-Intestinal Trials Group (non-profit organization)
References in periodicals archive ?
The EPOC (Eloxatin(R) for Peri-Operative Use) Study is a randomized multicenter phase III intergroup study sponsored and conducted by the EORTC (European Organization for Research and Treatment of Cancer), in collaboration with AGITG (Australasian Gastro-Intestinal Trials Group), EORTC GITCG (EORTC Gastrointestinal Tract Cancer Group), ALM-CAO (Arbeitsgruppe Lebermetastasen und -tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie), CRUK (Cancer Research UK) and FFCD (Fondation Francophone de Cancerologie Digestive).
Quality of life in patients with advanced colorectal cancer treated with cetuximab: Results of the NCIC CTG and AGITG CO.
The international, randomized, Phase III intergroup study was conducted by EORTC (European Organisation for Research and Treatment of Cancer), ISG (Italian Sarcoma Group) and AGITG (Australasian Gastrointestinal Trials Group).